BRONCOCHEM EXPECTORANT II

BRONCOCHEM EXPECTORANT II is an FDA-registered drug product whose active ingredient is ACETAMINOPHEN-CHLORPHENIRAMINE MALEATE-DEXTROMETHORPHAN HBR-GUAIFENESIN-PHENYLEPHRINE HCL. It is labelled by LABORATORIO MAGNACHEM INTERNATIONAL SRL taken by oral and marketed as a human otc drug product. Identifiers on file: NDC 65131-116, application part343, label effective 20161219. This page reproduces the FDA-approved label text so you can check what a product is, who makes it and how it is supplied before discussing it with a pharmacist or prescriber.

Across FDA labelling, products containing ACETAMINOPHEN-CHLORPHENIRAMINE MALEATE-DEXTROMETHORPHAN HBR-GUAIFENESIN-PHENYLEPHRINE HCL are most often described in connection with: nose itchy, bronchial congestion, respiratory passages, helps loosen, phlegm mucus, secretions make, productive antitussive, temporarilly relieves. Wording differs between labels, and the full indications section on this page takes precedence when it is present.

Indications & Use Bronchial congestion Irritation of the respiratory passages Nasal congestion Helps loosen phlegm (mucus) and dilute bronchial secretions to make coughs more productive Antitussive Temporarilly relieves allergy symptoms including runny nose, sneezing, stuffy nose, itchy nose, itchy throat, irritated and watery eyes, allergic rhinitis

Dosage and Administration Do not exceed 4 doses in a 24 hour period Adults and chuildren 12 years and over: (10mL or cc) using metered dosage spoon every 6 hours. Children 6 years up to 12 years: (5mL or cc) using metered dosage spoon every 6 hours

Warnings Unless directed by a physician do not take this product if persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, emphysema, or if cough is accompanied by excessive phlem (mucus). Likewise if you have heart disease, high blood pressure, thyroid disease, diabetes, or difficulty in urination due to enlargement of the prostate gland, if nervousness, dizziness, or sleeplesness occur, discontinue use or consult a doctor, if symptoms do not improve within 7 days or are accompainied by fever, consult a doctor. A persistent cough may be a sing of a serious condition. Stop use and ask a doctor if symptoms persist or last long that 5 days (children) or 7 days (adults), tend to return, arash, or persistent headache. As with any drug, if you are pregnant or nursing a baby; seek the advice of a healh professional before using this product. Unless directed by a doctor, do not take this product if you are presently taking another product containing Pseudoephedrine HCl, or if you are taking sedatives or trankilizers; it may increase the drowsiness effect. Avoid alcoholic beverages while taking this product. Use caution when driving a motor vehicle or operating machinery.

What is BRONCOCHEM EXPECTORANT II used for?
Indications & Use Bronchial congestion Irritation of the respiratory passages Nasal congestion Helps loosen phlegm (mucus) and dilute bronchial secretions to make coughs more productive Antitussive Temporarilly relieves allergy symptoms including runny nose, sneezing, stuffy nose, itchy nose, itchy throat, irritated and watery eyes, allergic rhinitis

Who makes BRONCOCHEM EXPECTORANT II?
LABORATORIO MAGNACHEM INTERNATIONAL SRL is the labeler of record for BRONCOCHEM EXPECTORANT II.

What form does BRONCOCHEM EXPECTORANT II come in?
administered by oral. Strengths and pack sizes vary by label, so compare the NDC on your pack with the identifier listed on this page.

Is BRONCOCHEM EXPECTORANT II prescription or over-the-counter?
The FDA label for this product is recorded as human otc drug. Marketing status can differ between strengths and countries, so check the dispensing rules where you live.

Has BRONCOCHEM EXPECTORANT II been recalled?
No FDA recall record in our database matches this product name or manufacturer. Recall data is updated periodically, so a very recent notice may not appear here yet.

Where does this information come from?
All content is reproduced from FDA Structured Product Labelling data via openFDA. It is provided for identification and reference only and is not medical advice.